Healthcarenews16 Apr, 2024Business
The global size of monoclonal antibody therapeutics market in terms of revenue was estimated to be worth USD 252.6 billion in 2024 and is poised to reach USD 497.5 billion by 2029, growing at a CAGR of 14.5% from 2024 to 2029. The monoclonal antibody therapeutics market is primarily driven by factors such as increasing prevalence of chronic diseases like cancer, autoimmune disorders, and infectious diseases. Technological advancements in antibody engineering and production processes also contribute significantly.
Lambertsen Filtenborg
188bet
Harmon Dwyer
Stallings Munck
Lassiter Dale
Thc Vape Australia
Magnusson Welsh
Nyholm Law
Nash Storgaard
Swain Martens